
Keywords: آرتریتروماتوئید; RA; rheumatoid arthritis; IFX; infliximab; ETN; etanercept; ADCC; antibody-dependent cellular cytotoxicity; CDC; complement-dependent cytotoxicity; CCP; cyclic citrullinated peptide; RF; rheumatoid factor; MMP-3; matrix-metalloproteinase-3; DAS28-ESR; dis